The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP1304-CMap - NLT_B: Toxicogenomic signatures after exposure to afatinib TSA9832-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib TSA9837-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib TSF14077-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 12.46 µM 1 subfactor(s) TSF14078-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 6.24 µM 1 subfactor(s) TSF14079-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 3.12 µM 1 subfactor(s) TSF14080-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 1.6 µM 1 subfactor(s) TSF14081-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.8 µM 1 subfactor(s) TSF14082-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.39 µM 1 subfactor(s) TSF14083-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.2 µM 1 subfactor(s) TSF14084-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.1 µM 1 subfactor(s) TSF14085-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.05 µM 1 subfactor(s) TSF14086-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 24.98 µM 1 subfactor(s) TSF14131-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 49.99 µM 1 subfactor(s) TSF14132-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 24.98 µM 1 subfactor(s) TSF14133-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 12.46 µM 1 subfactor(s) TSF14134-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 6.24 µM 1 subfactor(s) TSF14135-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 3.12 µM 1 subfactor(s) TSF14136-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 1.6 µM 1 subfactor(s) TSF14137-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.8 µM 1 subfactor(s) TSF14138-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.39 µM 1 subfactor(s) TSF14139-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.2 µM 1 subfactor(s) TSF14140-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.1 µM 1 subfactor(s) TSF14141-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.05 µM 1 subfactor(s) TSS14080-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 12.46 µM TSS14081-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 6.24 µM TSS14082-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 3.12 µM TSS14083-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 1.6 µM TSS14084-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.8 µM TSS14085-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.39 µM TSS14086-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.2 µM TSS14087-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.1 µM TSS14088-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 0.05 µM TSS14089-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to afatinib 24.98 µM TSS14134-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 49.99 µM TSS14135-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 24.98 µM TSS14136-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 12.46 µM TSS14137-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 6.24 µM TSS14138-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 3.12 µM TSS14139-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 1.6 µM TSS14140-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.8 µM TSS14141-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.39 µM TSS14142-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.2 µM TSS14143-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.1 µM TSS14144-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to afatinib 0.05 µM
TSP1304 - CMap - NLT_B: Toxicogenomic signatures after exposure to afatinib
Public
https://clue.io/data/NLT#NLT_B
Experimental design
No experimental design provided
Results
No results provided